Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients.
SourceBritish Journal of Cancer, 79, 7/8, (1999), pp. 1190-1198
Article / Letter to editor
Display more detailsDisplay less details
British Journal of Cancer
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.